subtypes

Related by string. subtype * * distinct subtypes . predominant subtype . Zaire subtype . H#N# subtype . H5 subtype . HIV subtype . virus subtype . subtype H#N# . receptor subtype . molecular subtypes . subtype selective NMDA receptor . influenza subtypes . tumor subtypes . receptor subtypes . histological subtypes . viral subtypes . H7 subtype . H7 subtypes . squamous subtype . lymphoma subtypes *

Related by context. All words. (Click for frequent words.) 79 subtype 67 molecular subtypes 66 clades 64 alleles 64 distinct subtypes 64 genotypes 63 histologies 63 polymorphisms 63 clade B 63 isoforms 63 genetic polymorphisms 63 serotypes 62 missense mutations 62 virulence genes 62 EGFR mutations 62 serogroups 62 cell lymphomas 62 lymphomas 61 epitopes 61 histological subtypes 61 pathogenic mechanisms 61 susceptibility loci 61 K ras mutations 61 FGFR2 61 susceptibility genes 61 epithelial tumors 61 MGUS 61 coinfection 60 circadian genes 60 rs# [004] 60 herpesviruses 60 phenotypes 60 isotypes 60 breast carcinomas 60 histologic subtypes 60 orthologs 60 genotype 60 genetic loci 60 hepatocellular carcinomas 60 seminomas 60 genetic aberrations 60 PTEN mutations 60 mutations 59 uPAR 59 astrocytomas 59 monogenic 59 oncoproteins 59 coding sequences 59 MAPK pathway 59 GSTP1 59 non Hodgkin lymphomas 59 lymphocytic 59 causal variants 59 chromosomal regions 59 genetic determinants 59 histological subtype 59 FLT3 59 etiologic agent 59 genetic alterations 59 IgA deficiency 59 cellular pathways 59 intergenic 59 homozygotes 58 loci 58 receptor subtypes 58 genes encoding 58 TGFBR1 * 6A 58 haplotype 58 subpopulations 58 HCV genotypes 58 etiologies 58 surface proteins hemagglutinin 58 etiologic 58 methylation patterns 58 neutralizing antibody 58 miRNA expression 58 clade 58 proto oncogene 58 enteroviruses 58 molecular abnormalities 58 herpes viruses 58 protein kinases 58 EGFRvIII 58 conserved sequences 58 splice variants 58 subfamilies 58 HBV genotype 58 amino acid residues 58 M. pneumoniae 58 DARPP 58 germline mutations 58 Genotypes 58 neoplastic 58 phenotype 58 CagA 58 Epstein Barr virus EBV 58 histologic subtype 58 viral subtypes 58 androgen receptor AR 58 MTHFR 58 genetic variants associated 58 P. falciparum 58 tumor subtypes 58 sporadic ALS 58 HBV genotypes 58 Sjögren syndrome 57 Non Hodgkin lymphomas 57 PCa 57 epigenetic mechanisms 57 serogroup 57 PTPN# 57 susceptibility gene 57 nanomolar 57 glycoproteins 57 biologic pathways 57 Plasmodium falciparum 57 prognostic marker 57 myeloproliferative diseases 57 P. ovale 57 functional polymorphism 57 DLBCL 57 histone modifications 57 haplogroups 57 gene rearrangements 57 etiologic factors 57 Subtypes 57 mRNA expression 57 SSc 57 HLA DRB1 * 57 protein isoforms 57 haplotypes 57 amino acid sequence 57 oncogenic 57 ERBB2 57 H5 viruses 57 activating mutation 57 spontaneous mutations 57 HLA B# 57 phosphatases 57 differentially expressed genes 57 ependymomas 57 Plasmodium parasites 57 C#Y 57 ABCB1 57 miRNAs 57 outer membrane proteins 57 Candida species 57 medulloblastomas 57 selective antagonists 57 KRAS mutations 57 pDCs 57 transmembrane protein 57 virulence determinants 57 serotonin receptor 57 S. aureus strains 57 genetic variants 57 C. trachomatis 57 capsular polysaccharide 57 germinal center 57 H. influenzae 57 NRTI resistance 57 clade C 57 narcolepsy cataplexy 56 synuclein 56 somatic mutations 56 clusterin 56 myeloproliferative neoplasms 56 bacterial genomes 56 virus subtype 56 microcephalin 56 essential thrombocythemia 56 CHIKV 56 underlying pathophysiology 56 #S rRNA genes 56 VEGF receptors 56 monozygotic twins 56 gene variants 56 H#K#me# 56 resistant isolates 56 epitope 56 pilocytic astrocytomas 56 missense mutation 56 dopamine receptor gene 56 lymphoid cells 56 clinicopathologic 56 IGF IR 56 V#F mutation 56 streptococci 56 heterozygous 56 phospholipase 56 MDR1 56 HPV# 56 ZNF# 56 breast cancer subtypes 56 cAMP signaling 56 prostate cancer CaP 56 DRD2 56 myelofibrosis polycythemia vera 56 adenocarcinomas 56 prognostic significance 56 IGFBP 56 Inflammatory bowel disease 56 HLA genes 56 mesotheliomas 56 mycobacteria 56 carcinoid 56 System IPSS 56 Leydig cell 56 CD8 responses 56 epigenetic alterations 56 myeloproliferative disorders 56 inhibitory receptor 56 histone deacetylases 56 Corynebacterium 56 pathologic 56 HTLV 56 gastric adenocarcinoma 56 pneumococcal serotypes 56 lymphocyte 56 tyrosine kinases 56 fluconazole resistant 56 mosaicism 56 biological pathways 56 dinucleotide 56 squamous 56 syndromal 56 constitutively active 56 neoplasms 56 rs# [001] 56 endophenotypes 56 MLH1 56 phenotypic differences 56 gene expression profiles 56 VHL gene 56 EGFR inhibition 56 phenotypically 56 subfamily 56 HLA DR 56 substrate specificity 56 gene mutations 56 glycoprotein 56 HPV subtypes 56 etiology 56 genomic alterations 56 rs# [003] 56 Enterobacteriaceae 56 neuraminidases 56 alpha synuclein gene 56 phosphorylated tau 56 HepG2 cells 56 predisposing factors 56 osteosarcomas 56 hypermethylation 56 murine models 56 monocytic 56 kinase inhibition 56 KIT mutations 56 activating mutations 56 cathepsins 56 UGT#A# * 56 clinicopathological 56 hamartomas 55 ansamycin 55 constitutively expressed 55 COL#A# 55 virulence factors 55 Chronic lymphocytic leukemia 55 pathogenesis 55 quasispecies 55 Cytotoxic T 55 pathogenic mutations 55 hyperplastic 55 gene polymorphisms 55 myeloproliferative 55 isoform 55 chromosome #q# [001] 55 Apolipoprotein 55 nicotinic receptors 55 coding genes 55 MYH9 gene 55 B lymphocytes 55 membrane proximal 55 HSV1 55 C. albicans 55 TLR3 55 serologic tests 55 arenaviruses 55 benign moles 55 beta1 integrin 55 serous ovarian cancer 55 BRAF mutations 55 #q#.# [002] 55 gene polymorphism 55 HLA DRB1 55 dual tropic 55 influenza subtypes 55 prognostic markers 55 serotype 55 urethritis 55 LRRK2 gene 55 K#R [002] 55 receptor binding 55 homodimers 55 microRNA expression 55 immunoreactivity 55 hepatoma 55 gastric carcinogenesis 55 leukaemias 55 gene locus 55 HbF 55 lymphoid 55 CD#b 55 gene loci 55 GSTM1 55 signaling pathways 55 PON1 55 homologs 55 receptor subtype 55 gene expression patterns 55 prognostic indicator 55 serovar 55 genes CYP#C# 55 microdeletions 55 CCR7 55 chronicity 55 superfamily 55 cell malignancies 55 TTR gene 55 sialic acids 55 EBV infection 55 Plasmodium vivax 55 viral genomes 55 pulmonary metastases 55 Rap1 55 promoter polymorphism 55 fascin 55 Salmonella serotypes 55 BRAF V#E 55 molecular mechanisms underlying 55 drug metabolizing enzymes 55 IgG4 55 syndromes 55 noncoding RNAs 55 FGFR1 55 lipid abnormalities 55 human metapneumovirus 55 GISTs 55 epithelia 55 S. maltophilia 55 nicotinic receptor 55 STK# [002] 55 biologic pathway 55 oncogenic HPV types 55 causative genes 55 transgene expression 55 Leukemias 55 Polycythemia vera 55 chromosomal alterations 55 paralogs 55 UGT#B# 55 diarrhea predominant IBS 55 LIS1 55 hereditary predisposition 55 allele 55 imatinib resistance 55 haplogroup 55 HLA alleles 55 lymphoma subtypes 55 X4 viruses 55 NNRTI resistance 55 streptococcal 55 activin 55 promoter methylation 55 MECP2 gene 55 KRAS oncogene 55 signal transduction pathways 55 SLC#A# [002] 55 P. gingivalis 55 mediated immunity 55 carcinoids 55 antigens 55 HDACs 55 sCJD 55 neuroendocrine cancers 55 SNP rs# [001] 55 superinfection 55 Polymorphisms 55 Th1 55 cystatin 55 flaviviruses 55 cytopathic 55 EBNA1 55 allelic variants 55 vivax 55 clonally 55 T#I [002] 55 Chlamydophila pneumoniae 55 HLA DQ2 55 chemokine receptors 55 eotaxin 55 Hemagglutinin 55 neoplasias 55 immunohistochemical staining 55 innate immune responses 55 sarcomatoid 55 HBeAg negative 55 metaplasia 54 inflammatory bowel diseases 54 C. jejuni 54 proteins 54 microdeletion 54 dissociative disorders 54 homozygosity 54 enterotypes 54 fluoroquinolone resistant 54 COX2 54 RNA sequences 54 miRNA genes 54 alpha2 54 IL#B 54 Medullary thyroid cancer 54 NS4A 54 metabolic enzymes 54 FDG uptake 54 paramyxoviruses 54 ncRNAs 54 poxvirus 54 rhinoviruses 54 #q# [001] 54 polymorphism 54 chromosomal rearrangement 54 precursor lesions 54 carcinomas 54 gastric carcinoma 54 fluoroquinolone resistance 54 serine protease 54 RNA viruses 54 mediated autoimmune diseases 54 pathological hallmark 54 cell acute lymphoblastic 54 single nucleotide polymorphism 54 HER2 expression 54 biochemical abnormalities 54 molecular pathways 54 viral isolates 54 #HT#A 54 rs# [002] 54 SPINK1 54 lysosomal storage diseases 54 papillary renal cell carcinoma 54 receptors 54 intracellular bacteria 54 carcinoid tumors 54 mutated genes 54 papillary 54 serotonin receptors 54 fusogen 54 causative mutations 54 trans retinoic acid 54 Activating mutations 54 tumor antigens 54 Janus kinase 54 SMAD4 54 brucei 54 serotonin transporter 54 subunit 54 alexithymia 54 pneumoniae 54 pathophysiological 54 SNPs 54 genetic locus 54 cell signaling pathways 54 antigen CD# 54 malignant lesions 54 hypermethylated 54 lung carcinomas 54 TMEM#B 54 prognostic factor 54 IL 1ß 54 coding exons 54 NKT cells 54 dengue viruses 54 costimulatory 54 germline mutation 54 Wwox 54 Aurora kinases 54 K ras gene 54 mycosis fungoides 54 oncogenes 54 Plasmodium 54 metabolizing enzymes 54 replicase 54 opportunistic pathogen 54 nonmelanoma skin cancers 54 coinfected 54 modifier genes 54 parainfluenza virus 54 PIK3CA 54 segmental duplications 54 Clostridia 54 tumor xenograft models 54 transgenic mouse model 54 supratentorial 54 pRb 54 autism susceptibility genes 54 monocyte 54 apolipoprotein E gene 54 APOE e4 54 HDAC enzymes 54 steatohepatitis 54 PB1 F2 54 staphylococci 54 interleukins 54 KIAA# 54 cytosine 54 heterozygote 54 fig. S2 54 genetic variations 54 hydroxylase 54 Serotype 54 basal cell carcinoma BCC 54 CYP#D# gene 54 biochemical marker 54 homologues 54 Borrelia 54 BRAF mutation 54 TACI mutations 54 human herpesvirus 54 coronaviruses 54 tumor suppressor genes 54 cytogenetic abnormalities 54 genetic mutations 54 tRNA synthetase 54 BCR ABL1 54 VKORC1 54 NKG2D 54 S. Typhimurium 54 HCV infection 54 rotaviruses 54 Mutational 54 neuroblastomas 54 receptor proteins 54 CD8 + 54 astrocytic 54 normal karyotype 54 underlying molecular mechanisms 54 generalized vitiligo 54 aetiology 54 variants 54 de novo mutations 54 malignant lymphoma 54 esophageal squamous cell carcinoma 54 c MYC 54 tyrosine phosphorylation 54 myopathies 54 amino acid substitutions 54 paragangliomas 54 subsyndromal 54 thymoma 54 demyelinating diseases 54 Squamous 54 HBx 54 protein tyrosine phosphatases 54 potent inhibitors 54 RASSF1A 54 staphylococcal 54 genetic polymorphism 54 cytotoxin 54 aT cell 54 demyelinating 54 oncogenesis 54 subtyped 54 nucleotide sequence 54 swine origin 54 nucleoli 54 PDE#A 54 miRNA molecules 54 granulosa cell 54 KRAS status 54 goblet cells 54 lymphocyte activation 54 TMPRSS2 ERG 54 mRNA molecules 54 serologically 54 Genetic variants 53 dimers 53 anaplastic 53 UCRs 53 sequence homology 53 Clusterin 53 genotypic 53 pathological hallmarks 53 causative agent 53 karyotypes 53 IL#R 53 receptor gene 53 TIMP 53 GBM tumors 53 Gleevec resistant 53 GABHS 53 Subtype 53 epithelioid 53 cell adhesion molecules 53 breast carcinoma 53 N Myc 53 receptor antagonists 53 ALK gene 53 IDH2 53 methylenetetrahydrofolate reductase 53 pathophysiological mechanisms 53 overexpressing 53 CYP#D# 53 heterozygotes 53 JAK2 enzyme 53 catenin 53 HCMV 53 CD8 cells 53 monozygotic twin 53 Trichophyton rubrum 53 mGluRs 53 MLL gene 53 VZV 53 HBeAg positive 53 avian influenza viruses 53 neurological manifestations 53 tetramers 53 rotavirus strains 53 EGFR mutant 53 epithelial tissues 53 TNFR1 53 breast cancer susceptibility genes 53 mTOR inhibitors 53 flavivirus 53 genes 53 gastric cancers 53 GBA mutations 53 Genetic variation 53 mucinous 53 Smad3 53 K#N 53 pituitary adenomas 53 miR #a [001] 53 suppressor cells 53 HCV genotype 53 isoenzymes 53 cysteine residues 53 C. neoformans 53 beta lactamases 53 viral strains 53 papillomas 53 meningiomas 53 clinically heterogeneous 53 selective inhibitors 53 tigecycline 53 paraganglioma 53 pheochromocytoma 53 coinfections 53 indels 53 familial pancreatic cancer 53 ApoE 53 immune dysregulation 53 neuropsychiatric disorder 53 CHD7 53 mutated K ras 53 LEAPS vaccines 53 E selectin 53 asymptomatic carriers 53 biochemical pathways 53 neoplasm 53 inbred strains 53 DQB1 * 53 ribosomal proteins 53 distinct lineages 53 autoantibody 53 obstructive coronary artery 53 ortholog 53 TTR amyloidosis 53 mutant allele 53 eosinophilic 53 HDACi 53 candidemia 53 Streptococcus pyogenes 53 operon 53 lymph node metastasis 53 caveolin 53 peptide sequences 53 childhood leukemias 53 oligomeric 53 S. cerevisiae 53 perilipin 53 subunits 53 LTBI 53 viral proteins 53 posttranslational modifications 53 phosphate S1P 53 MeCP2 gene 53 small lymphocytic lymphoma 53 chitinase 53 Lymphocyte 53 HER2 HER3 53 vimentin 53 immunoregulatory 53 causative agents 53 synthetic analogues 53 cyclin E 53 lysine residues 53 B7 H3 53 IgG antibodies 53 malignant prostate 53 CD# expression [002] 53 transmembrane proteins 53 predictive biomarkers 53 antibody mediated 53 lung adenocarcinomas 53 amyloid fibrils 53 differentially regulated 53 CDK4 53 CEACAM1 53 protein tyrosine kinase 53 S.aureus 53 NKX2 53 recombinants 53 biomarkers 53 homozygote 53 molecular underpinnings 53 Mechanistic studies 53 IgG antibody 53 oncogenic transformation 53 GNAQ 53 HT 2A 53 epilepsies 53 protein encoded 53 estrogen receptor beta 53 S OIV 53 operons 53 P. malariae 53 ANCA associated 53 nonmelanoma 53 morphologically 53 NSCLC tumors 53 extracellular domain 53 immunized mice 53 protein kinase 53 causative mutation 53 Entamoeba histolytica 53 tumor suppressor protein 53 TRP channels 53 EphB4 53 CDH1 53 CRF1 receptor 53 CNVs 53 PTEN gene 53 CYP#C# [002] 53 neuroinflammation 53 RRM1 53 genomic deletions 53 ESBLs 53 nonalcoholic steatohepatitis NASH 53 #q# deletion 53 Plasmodium species 53 IGF 1R 53 mitochondrial gene 53 metabolic abnormalities 53 proteobacteria 53 frontotemporal dementia 53 micro RNA 53 pharmacodynamic biomarkers 53 immunostaining 53 protein tyrosine phosphatase 53 PDGF receptor 53 peptide antigens 53 HHV 6 53 PKCi 53 receptor subunits 53 lymphoid malignancies 53 metastatic lymph nodes 53 SNP rs# [002] 53 LRP6 53 MMP# 53 Histologically 53 unmutated 53 leiomyomas 53 subcellular compartments 53 #β HSD1 53 Epstein Barr virus 53 allele frequency 53 iNOS 53 IL 1β 53 metastatic prostate 53 Genotype 53 M#V mutation 53 TT genotype 53 adhesion molecules 53 nonmetastatic 53 phenotypic variation 53 lymphocytosis 53 glycosylated 53 atopic diseases 53 EGF receptors 53 EGFR mutation 53 ADPKD 53 gambiae 53 T. gondii 53 ADAM# 53 KLF4 53 intron 53 Acute lymphoblastic leukemia 53 mesothelin 53 Mus musculus 53 C1q 53 chromosome #q#.# [001] 53 orchitis 53 Trichomonas vaginalis 53 bronchial epithelial cells 53 susceptibility locus 53 molecularly defined 53 inherited mutations 53 retrovirus XMRV 53 QTLs 53 polymicrobial 53 c Myb 53 renal tumors 53 GPC5 53 IFN γ 53 virus XMRV 53 serine threonine kinases 53 E#F# 53 CD4 + CD# 53 induce apoptosis 53 USP# 53 ApoE gene 53 GBMs 53 adaptive immunity 53 N. gonorrhoeae 53 D#N 53 granulomatous 53 VEGF receptor 53 leukocyte recruitment 53 BCL#A 53 subtyping 53 MHC genes 53 #S rRNA gene 53 tropomyosin 53 IDH mutations 52 #q#.# [001] 52 Alu elements 52 non coding RNA 52 follicular dendritic cells 52 colorectal carcinoma 52 estrogen receptor ER 52 Relapsing remitting MS 52 antiviral therapies 52 neuropsychiatric disorders 52 lymphoproliferative disorders 52 bilaterians 52 TEAEs 52 CXCR4 52 euthymic patients 52 oligodendrogliomas 52 penetrance 52 downregulated 52 immunopathology 52 CDK8 52 C. pneumoniae 52 receptor protein 52 promoter hypermethylation 52 incidentalomas 52 Alleles 52 IFN gamma 52 mitochondrial toxicity 52 cysteine protease 52 p# deficient 52 protein kinase C 52 melatonin receptor 52 xenograft models 52 miR #b [002] 52 FTLD 52 H#N# subtype 52 neurofibromas 52 allele frequencies 52 mtDNA mutations 52 SE alleles 52 dermatophytes 52 glycogen synthase kinase 52 signaling cascades 52 small molecule inhibitors 52 Mycoplasma pneumoniae 52 c KIT 52 malignancies 52 chromosome #p#.# 52 micro RNAs 52 progressive neurodegenerative disorder 52 coxsackievirus 52 VNTR 52 T. brucei 52 GSTT1 52 metalloproteinase 52 familial ALS 52 APOL1 52 suppressor gene 52 lactis 52 Fas ligand 52 cell lymphoma DLBCL 52 antibody titers 52 ALK mutations 52 familial clustering 52 pathophysiologic 52 amyloid cascade 52 dopamine transporter gene 52 downregulate 52 pneumococcal infection 52 defensin 52 Nedd4 52 orthologous 52 DNMT1 52 haemagglutinin 52 lineages 52 mutant enzymes 52 effector function 52 cadherin 52 CFH gene 52 P aeruginosa 52 p# MAPK 52 K ras 52 codons 52 karyotype 52 poor metabolizers 52 somatostatin 52 gliomas 52 interleukin IL -# 52 Diffuse Large B 52 gonococcal 52 MAPK 52 nAChR 52 neuropsychiatric diseases 52 ERK signaling 52 ORFs 52 viral antigens 52 FGFs 52 mGluR 52 cell adhesion molecule 52 kaempferol 52 Typhi 52 Lymphocytic 52 heterodimers 52 variant alleles 52 SARS CoV 52 Follicular lymphoma 52 humoral 52 lung adenocarcinoma 52 S. aureus isolates 52 autoantibodies 52 E. faecalis 52 Inflammatory bowel diseases 52 NOMID 52 interferon γ 52 Upregulation 52 secreted proteins 52 ErbB2 52 subclinical 52 cyclins 52 c MET 52 S/GSK# 52 erythrocytes 52 HCV replicon 52 chronic HBV infection 52 evolutionarily conserved 52 splice junctions 52 HER2 amplification 52 PARP inhibition 52 HMGA2 52 L. pneumophila 52 ccRCC 52 epistasis 52 subpopulation 52 methicillin susceptible Staphylococcus aureus 52 immunoglobulin genes 52 myeloid 52 unipolar depression 52 MYCN amplification 52 gene amplification 52 inflammatory demyelinating 52 serum BDNF 52 HCV infections 52 Chronic Lymphocytic Leukemia CLL 52 neuraminidase NA 52 endogenous ligands 52 Hashimoto thyroiditis 52 Pneumocystis carinii pneumonia 52 HLA molecules 52 chromosome rearrangements 52 mammary cells 52 Phylogenetic analysis 52 diagnostic biomarkers 52 S#A# [002] 52 serotype #A 52 MMP inhibitors 52 CCL#L# 52 botulinum neurotoxin

Back to home page